Examples described in the Workshop Report of the 2017 EAHP/SH meeting included cases of ET with del(5q) or PMF with SF3B1 p.K666N mutation and ring sideroblasts, in addition to a canonical JAK2 V617F mutation. The gene discussed is JAK2; the disease is essential thrombocythemia.